iKang Healthcare Group, Inc. (KANG) Shares Sold by OxFORD Asset Management LLP

OxFORD Asset Management LLP trimmed its stake in iKang Healthcare Group, Inc. (NASDAQ:KANG) by 13.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 522,095 shares of the medical research company’s stock after selling 77,905 shares during the period. OxFORD Asset Management LLP owned about 0.75% of iKang Healthcare Group worth $7,027,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Athos Capital Ltd acquired a new stake in shares of iKang Healthcare Group during the 2nd quarter valued at about $8,622,000. SG Americas Securities LLC boosted its position in shares of iKang Healthcare Group by 14.6% during the 2nd quarter. SG Americas Securities LLC now owns 44,608 shares of the medical research company’s stock valued at $547,000 after acquiring an additional 5,700 shares in the last quarter. FIL Ltd boosted its position in shares of iKang Healthcare Group by 45.4% during the 2nd quarter. FIL Ltd now owns 360,922 shares of the medical research company’s stock valued at $4,429,000 after acquiring an additional 112,615 shares in the last quarter. GLG Partners LP boosted its position in shares of iKang Healthcare Group by 15.5% during the 2nd quarter. GLG Partners LP now owns 1,754,570 shares of the medical research company’s stock valued at $21,529,000 after acquiring an additional 235,056 shares in the last quarter. Finally, Pictet Asset Management Ltd. acquired a new stake in shares of iKang Healthcare Group during the 3rd quarter valued at about $330,000. Institutional investors own 33.11% of the company’s stock.

Separately, BidaskClub upgraded shares of iKang Healthcare Group from a “sell” rating to a “hold” rating in a research report on Tuesday, August 15th.

Shares of iKang Healthcare Group, Inc. (KANG) opened at $14.62 on Monday. The company has a current ratio of 0.78, a quick ratio of 0.76 and a debt-to-equity ratio of 0.30. iKang Healthcare Group, Inc. has a 12-month low of $11.70 and a 12-month high of $18.41.

iKang Healthcare Group (NASDAQ:KANG) last announced its quarterly earnings results on Thursday, September 14th. The medical research company reported $0.06 earnings per share (EPS) for the quarter. iKang Healthcare Group had a negative net margin of 2.16% and a negative return on equity of 2.68%. The firm had revenue of $115.60 million during the quarter.

TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.com-unik.info/2017/12/04/ikang-healthcare-group-inc-kang-shares-sold-by-oxford-asset-management-llp.html.

iKang Healthcare Group Profile

iKang Healthcare Group, Inc provides preventive healthcare solutions, including a range of medical examinations services and value-added services, including disease screening, dental services and other services in China. The Company’s segments include medical examinations and other medical services, and dental services.

Want to see what other hedge funds are holding KANG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iKang Healthcare Group, Inc. (NASDAQ:KANG).

Institutional Ownership by Quarter for iKang Healthcare Group (NASDAQ:KANG)

What are top analysts saying about iKang Healthcare Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for iKang Healthcare Group Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit